about
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivoLocalization and regulation of MuSK at the neuromuscular junctionCloning and in situ hybridization of type 2A and 2B rat skeletal muscle myosin tail region: implications for filament assemblyThe histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogrammingControl of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load.Molecular brakes regulating mTORC1 activation in skeletal muscle following synergist ablation.Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1Western Blotting Inaccuracies with Unverified Antibodies: Need for a Western Blotting Minimal Reporting Standard (WBMRS).Cardiac proteasome activity in muscle ring finger-1 null mice at rest and following synthetic glucocorticoid treatment.A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation.Age-related deficits in skeletal muscle recovery following disuse are associated with neuromuscular junction instability and ER stress, not impaired protein synthesis.mTOR signaling and the molecular adaptation to resistance exercise.Resistance exercise, muscle loading/unloading and the control of muscle mass.The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.Disuse-induced muscle wasting.Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy.Muscle hypertrophy is associated with increases in proteasome activity that is independent of MuRF1 and MAFbx expression.Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits.Glucocorticoids and Skeletal Muscle.Acute resistance exercise activates rapamycin-sensitive and -insensitive mechanisms that control translational activity and capacity in skeletal muscle.Muscle-specific and age-related changes in protein synthesis and protein degradation in response to hindlimb unloading in rats.Control of skeletal muscle atrophy in response to disuse: clinical/preclinical contentions and fallacies of evidenceRole of contraction duration in inducing fast-to-slow contractile and metabolic protein and functional changes in engineered muscle.Age-related Differences in Dystrophin: Impact on Force Transfer Proteins, Membrane Integrity, and Neuromuscular Junction Stability.Contribution of mechanical unloading to trabecular bone loss following non-invasive knee injury in mice.Effect of severe short-term malnutrition on diaphragm muscle signal transduction pathways influencing protein turnover.Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting.Chronic high fat feeding attenuates load-induced hypertrophy in mice.Age-related deficit in load-induced skeletal muscle growth.Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.Hibernation: the search for treatments to prevent disuse-induced skeletal muscle atrophy.CrossTalk opposing view: The dominant mechanism causing disuse muscle atrophy is proteolysis.Rebuttal from Michael B. Reid, Andrew R. Judge and Sue C. Bodine.Analysis of skeletal muscle hypertrophy in models of increased loading.A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy.Evaluation of Akt/mTOR activity in muscle atrophy after rotator cuff tears in a rat model.A new cover and updated scope for the Journal of Applied Physiology.Extracellular matrix scaffolds for treatment of large volume muscle injuries: A review.
P50
Q28206290-A0CE2836-B1A7-47C4-A131-4671F9FB3B26Q28572740-DF3F0962-C5B2-4B47-B350-0091B3047E7BQ28580150-D3E4AF64-8253-43C5-859C-162199DA0C51Q28590118-4C5F3313-BD4A-451A-89F2-9E9BDEAA4025Q30308851-4E9AA69B-7440-4C29-B2A2-3EF740FE9787Q34062789-09695EC4-4A08-4F4C-B542-732CD4B61707Q34200869-87616443-3E76-4D10-9348-3C8D1087A237Q34490107-8D868F81-8E06-4587-9E6D-20E53E5F006BQ35543645-6D751714-838D-474F-8463-284CE208A081Q35993669-68DCB47F-D429-4E28-9088-A8F2EE661A09Q36055551-0BA894FC-FE58-4206-B8F7-20853C695355Q36601672-BAF55CD5-EF86-46E2-ADD2-2E81524FEB09Q36649624-7857F65E-7771-411C-81C8-5EE794979378Q36673070-C7413B80-C181-4E8F-870B-4BB479437D70Q37120241-6FC570CA-7246-4479-921A-B0BA4BADA5EAQ37377797-61C4F30D-D92E-4388-99EE-00DCEDC08E85Q37441036-2A41BBCD-F440-495C-A6EA-E1FE504F5DF5Q37596053-2014462A-8452-4962-9C89-27E4DB13624EQ38389158-733EB230-9F9A-4784-82C3-ABDE91336503Q38555448-EDCEE68B-9251-45CD-9274-075FDB60F13FQ38821101-972C6F0E-D75A-4528-AE32-5D7A994B5906Q38881080-B17DFCC8-D905-4A4E-8E80-41E4F7A885C8Q38887437-5FA14215-8784-49C9-9747-9458B4BF77E7Q38889200-1441788F-6356-4800-92B3-12A3508445DDQ39628731-C3A77371-D878-4ADD-BE2D-5CC6A2B2DDF3Q40041956-6132AE4E-D3A5-4356-BA21-D45785161B77Q40350084-5A5D1C7A-EB67-49C8-A5D8-A7BAE341C6B0Q40767544-B32066C7-9CFF-4D15-B1B5-043B349AEE36Q42085122-94D516BC-6818-4363-8460-9FE702D9FD8CQ43263022-37CFABBC-C11B-4F60-867A-276909C2BF24Q43831608-44F862ED-FEFD-4D4A-9F22-53CC00DF74B4Q44904396-8C83F528-BD66-455D-8873-9F128DDF84E3Q46300378-2010F72A-E95F-4AA9-A0E5-6F2A33538A93Q46833640-1134F744-FD46-4B07-8281-F0A211470BDBQ46875116-15927C5A-34E1-45B8-95F9-54A9786068C7Q46876537-08D7C966-8FA0-408A-A2FE-81520ECF2D25Q46921000-B53E35BF-ED74-43A7-A874-804D4BA91880Q48721193-8FA6C8AC-74A9-4DAC-A21D-695C2B1EA966Q52708900-89E0D598-4B92-4F74-B8A4-08EA3192DE3DQ53421667-9296D74B-4082-476D-8414-F3A5203E9130
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sue C Bodine
@ast
Sue C Bodine
@en
Sue C Bodine
@es
Sue C Bodine
@nl
type
label
Sue C Bodine
@ast
Sue C Bodine
@en
Sue C Bodine
@es
Sue C Bodine
@nl
prefLabel
Sue C Bodine
@ast
Sue C Bodine
@en
Sue C Bodine
@es
Sue C Bodine
@nl
P106
P1153
6603806538
P31
P496
0000-0002-5742-9145